Trade Engine

Dorian Wells brings more than a decade of experience as a biotech analyst to Trade Engine’s healthcare desk. Dorian specializes in pipelines, payer dynamics, and the translation of clinical data into commercial reality. Readers can expect pre-catalyst primers, post-readout sanity checks, and coverage that connects mechanism of action to market size and peak sales assumptions. Dorian’s work has been quoted in sector newsletters and he regularly moderates panels on valuation through the clinic-to-market arc. He writes with the conviction that Phase 2 should be readable by non-scientists, building notes that de-risk complexity without oversimplifying. When not parsing abstracts, Dorian volunteers at science fairs and collects well-designed trial schematics, proving that good diagrams beat buzzwords every time.